JOHN J KOKEMOR
Allopathic & Osteopathic Physicians|Internal Medicine NEW ORLEANS, LA NPI 1013917517
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine LA Novo Nordisk AS All categories
General Payments — all program years on this page
$1,347.66
- Category: General Payments
- Program years: PY2018–2019
- Record count: 96
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $495.68 across 37 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $495.68 | 37 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $112.04 | 9 |
| GlaxoSmithKline, LLC. | $77.84 | 6 |
| Janssen Pharmaceuticals, Inc | $45.27 | 3 |
| Astellas Pharma US Inc | $44.15 | 3 |
| Amarin Pharma Inc. | $37.60 | 3 |
| SANOFI-AVENTIS U.S. LLC | $29.24 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.67 | 1 |
| Daiichi Sankyo Inc. | $15.53 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.46 | 1 |
| Acerta Pharma LLC | $13.75 | 1 |
| Relypsa, Inc. | $13.57 | 1 |
| Merck Sharp & Dohme Corporation | $13.50 | 1 |
| Shire North American Group Inc | $12.95 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $12.50 | 1 |
| Lilly USA, LLC | $11.98 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $11.75 | 1 |
| PFIZER INC. | $10.88 | 1 |
By program year
Records — PY2019 (37)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.